English source-aligned edition
Karl Brandt
Karl Brandt served as Hitler's personal physician, co-director of the T4 programme and Reich health commissioner. The profile reconstructs the person’s function in Germany and Austria, with authority in the concentration-camp medical system through documented office, decisions, supervision or operational conduct. It does not assign every crime committed by an institution or region to one individual.
Confirmed findings
- In autumn 1939 Hitler authorised Brandt and Philipp Bouhler to organise the killing of patients classified by the regime as unworthy of life.
- Brandt co-directed the T4 programme, whose six killing centres used gas chambers and whose methods and personnel were later transferred to Operation Reinhard.
- After receiving wider health authority in 1942–1944, Brandt knew of and accepted criminal experiments on concentration-camp prisoners.
Place in the chain of responsibility
Brandt supplied medical authority, access to Hitler and programme-level supervision to organised murder. Responsibility for selections, transport and killings was also borne by T4 administrators, physicians and facility personnel.
Key events and mechanisms
- Hitler's backdated T4 authorisation, dated 1 September 1939
- operation of the six central T4 killing facilities, 1940–1941
- Doctors' Trial in Nuremberg, 1946–1947
The circle records authority, function and agency. Several profiles may describe different parts of the same persecution chain, so profile-level totals must not be added together.
Postwar accountability
An American military tribunal convicted Brandt of war crimes, crimes against humanity and membership in the criminal SS in the Doctors' Trial. Sentenced to death on 20 August 1947, he was hanged at Landsberg prison on 2 June 1948.
Limits of the evidence
The profile distinguishes Brandt's programme and health-system authority from the individual conduct of every doctor and from killings conducted outside his documented remit.
Sources
The source set combines institutional, archival, trial or scholarly material from at least two independent publishers.
